Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The serotonin transporter (5HTT) may be associated with the pathogenesis of major depressive disorder (MDD). The 5HTT‐linked polymorphic region (5HTTLPR) genotype may determine how levels of 5HTT mRNA are influenced by promoter methylation. We examined the association of 5HTT gene methylation, which influences gene expression, and the 5HTTLPR genotype before antidepressant treatment and expression before and after treatment. The aims of this study were (1) to investigate the association between 5HTT methylation or expression in leukocytes and depression and (2) to investigate a possible effect of 5HTT methylation, expression, and genotype on clinical symptoms in MDD. The 5HTTLPR genotype was significantly associated with mean methylation levels in patients only (patients: r = 0.40, p = 0.035, controls: p = 0.96). The mean methylation level was significantly increased in patients compared with controls (patients: 5.30 ± 0.24, controls: 4.70 ± 0.19, unpaired t‐test, p = 0.04). 5HTT expression using real‐time PCR and Taqman probes was increased in unmedicated patients compared with controls and then decreased 8 weeks after antidepressant treatment. The mean 5HTT expression level was not associated with the 5HTTLPR genotype in patients or controls. Increased depressive symptoms were related to decreased levels of methylation. Copyright © 2016 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Porcelli, S., Fabbri, C., & Serretti, A. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.10.003 · Cited by 331 · cited 2×
“Because of the success of antidepressant drugs that target the serotonin transporter (5HTT) system and the critical role of 5HTT in terminating serotonergic neurotransmission, polymorphic variants of the 5HTT gene have been widely studied as candidates for disease causation (Porcelli et al., 2012; Gryglewski et al., 2…”
BackgroundDevlin, A. M., Brain, U., Austin, J., & Oberlander, T. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012201 · Cited by 308 · cited 6×
“In the whole sample, only minor mean methylation (less than 10%) across the nine CpGs was observed in the investigated amplicon, consistent with previous studies (Philibert et al., 2008; Devlin et al., 2010; Alasaari et al., 2012; Kang et al., 2013; Zhao et al., 2013).”
BackgroundResultInfluentialPhilibert, R. A., Sandhu, H., Hollenbeck, N., Gunter, T., Adams, W., & Madan, A. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30657 · Cited by 300 · cited 6×
“In the whole sample, only minor mean methylation (less than 10%) across the nine CpGs was observed in the investigated amplicon, consistent with previous studies (Philibert et al., 2008; Devlin et al., 2010; Alasaari et al., 2012; Kang et al., 2013; Zhao et al., 2013).”
BackgroundResultInfluentialAssociation of SLC6A4 methylation with early adversity, characteristics and outcomes in depression
Kang, H.-J., Kim, J.-M., Stewart, R., Kim, S.-Y., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Shin, M.-G., & Yoon, J.-S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.01.006 · Cited by 254 · cited 7×
“In the whole sample, only minor mean methylation (less than 10%) across the nine CpGs was observed in the investigated amplicon, consistent with previous studies (Philibert et al., 2008; Devlin et al., 2010; Alasaari et al., 2012; Kang et al., 2013; Zhao et al., 2013).”
BackgroundResultInfluentialMeta-analysis of molecular imaging of serotonin transporters in major depression
Gryglewski, G., Lanzenberger, R., Kranz, G. S., & Cumming, P. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.82 · Cited by 227 · cited 2×
“Because of the success of antidepressant drugs that target the serotonin transporter (5HTT) system and the critical role of 5HTT in terminating serotonergic neurotransmission, polymorphic variants of the 5HTT gene have been widely studied as candidates for disease causation (Porcelli et al., 2012; Gryglewski et al., 2…”
BackgroundOkada, S., Morinobu, S., Fuchikami, M., Segawa, M., Yokomaku, K., Kataoka, T., Okamoto, Y., Yamawaki, S., Inoue, T., Kusumi, I., et al. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.02.002 · Cited by 125 · cited 2×
“In contrast, Okada et al. reported no significant difference between unmedicated MDD patients and healthy controls at any 5HTT promoter CpG site (Okada et al., 2014).”
Background
Cited by
Yuan, M., Yang, B., Rothschild, G., Mann, J. J., Sanford, L. D., Tang, X., Huang, C., Wang, C., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01519-z · Cited by 246
Schneider, I., Kugel, H., Redlich, R., Grotegerd, D., Bürger, C., Bürkner, P.-C., Opel, N., Dohm, K., Zaremba, D., Meinert, S., et al. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.273 · Cited by 86
The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review
Webb, L. M., Phillips, K. E., Ho, M. C., Veldic, M., & Blacker, C. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030826 · Cited by 84
“2016 discovered that decreased levels of CpG-3 and CpG-5 methylation were associated with more severe depression and increased CpG-2 methylation was associated with increased clinical improvement with treatment [70].”
BackgroundInfluentialZhou, J., Li, M., Wang, X., He, Y., Xia, Y., Sweeney, J. A., Kopp, R. F., Liu, C., & Chen, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.674273 · Cited by 56
Wang, T., Li, L., Yue, Y., Liu, X., Chen, S., Shen, T., Xu, Z., & Yuan, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.042 · Cited by 10
Metadata
- Authors
- Iga, J., Watanabe, S., Numata, S., Umehara, H., Nishi, A., Kinoshita, M., Inoshita, M., Shimodera, S., Fujita, H., & Ohmori, T.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2016-03-23
- Volume
- 31
- Issue
- 3
- Pages
- 193-199
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W2311884719
- Cited by
- 45
- References
- 6
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder. https://app.cochat.ai/papers/10.1002/hup.2527
- The paper
- Iga, J., Watanabe, S., Numata, S., Umehara, H., Nishi, A., Kinoshita, M., Inoshita, M., Shimodera, S., Fujita, H., & Ohmori, T. (2016). Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.2527
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.